DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 050633
NDA 050633 describes CEFPIRAMIDE SODIUM, which is a drug marketed by Wyeth Ayerst and is included in one NDA. Additional details are available on the CEFPIRAMIDE SODIUM profile page.
The generic ingredient in CEFPIRAMIDE SODIUM is cefpiramide sodium. There is one drug master file entry for this compound. Additional details are available on the cefpiramide sodium profile page.
The generic ingredient in CEFPIRAMIDE SODIUM is cefpiramide sodium. There is one drug master file entry for this compound. Additional details are available on the cefpiramide sodium profile page.
Summary for 050633
| Tradename: | CEFPIRAMIDE SODIUM |
| Applicant: | Wyeth Ayerst |
| Ingredient: | cefpiramide sodium |
| Patents: | 0 |
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 1GM BASE/VIAL | ||||
| Approval Date: | Jan 31, 1989 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 2GM BASE/VIAL | ||||
| Approval Date: | Jan 31, 1989 | TE: | RLD: | No | |||||
Profile for product number 005
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 10GM BASE/VIAL | ||||
| Approval Date: | Jan 31, 1989 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
